Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07328948 in Healthy Chinese Adult Participants
NCT07455240Phase 1Completed
- Sponsor
- Pfizer
- Start
- Mar 2026
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PF-07328948 in heart failure (HF), sponsored by Pfizer. Primary endpoints: Maximum Observed Plasma Concentration at Day 7 and Area under the plasma concentration at Day 7. Started Mar 2026; status: completed.
02
Drugs
PF-07328948
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07455240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07455240.